We all want the coronavirus to die off. It is the government’s job to spin reality to keep up the country’s morale. It is the prudent investor’s job to discern the truth.

The key questions for investors are: Where is the bottom in the stock market? Should you buy or sell stocks now?

Let’s examine with the help of a chart.

Please click here for a chart of the Dow Jones Industrial Average ETF DIA which tracks the Dow Jones Industrial Average DJIA.

Note the following:

• Look at the last bar. After touching the top band of the mother of support zones, the stock market has moved above the top band of the support/resistance zone. From a technical perspective, this shows significant optimism in the face of worsening coronavirus news.

• The chart shows that RSI (relative strength index) is nowhere near the level shown at the last major bottom. This indicates there is significant risk in this market that investors are underappreciating.

• The chart shows the Arora call on Jan. 22 that the coronavirus could cause problems for the stock market. This call was repeated on Jan. 30. Meanwhile, the S&P 500 Index SPX,  was on its way to new high Feb. 19.

• When the Dow was in 16,000-point range, I was calling for the index to reach 30,000 while President Trump was in office.

• When the Dow reached almost 30,000, I didn’t raised my target. It was not because I knew the coronavirus would come along, but because our adaptive ZYX Asset Allocation Model was keeping us cautious.

Where’s the bottom?

The mother of support zones has an 80% probability of holding — this along with RSI should be the main reference points to look for a bottom. There is simply too much optimism in the stock market, and in many cases investors are buying without doing research.

Here are a few examples:

• Abbott Laboratories ABT has come up with a coronavirus test that takes five minutes. The revenues from the coronavirus test will dwarf those that Abbott is likely to lose due to issues related to coronavirus. Investors are running up the stock.

• Johnson & Johnson JNJ  is making great progress on a coronavirus vaccine. Johnson & Johnson is likely to sell the vaccine at cost. This will have no material increase in earnings. Investors are running up the stock.

• General Motors GM will make ventilators. It is selling them at cost, so they will have no impact on earnings. Investors are running up the stock.

• Medtronic MDT makes ventilators, which are a small portion of its business. At the same time, Medtronic is suffering because its sales are likely to drop due to the postponement of non-essential surgeries. Investors aren’t seeing the whole picture. And, yes, they are running up the stock….Read more at MarketWatch.

A knowledgeable investor would have turned $100,000 into over $1,000,000 with the help from The Arora Report. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.